GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
14.3829 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
13.4225 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, BCL2, CA3, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, HSD11B2, HSD17B2, MMP2, MMP9, PPARA, PRKCB, PRKCD, PRKCE, TRPV1, TYR |
10.5692 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, BCL2, CA2, CA3, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, HSD11B2, HSD17B2, MCL1, MMP2, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, TRPV1, TYR |
9.83915 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALPL, BCL2, CA2, CA3, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, HSD11B2, HSD17B2, MCL1, MMP2, MMP9, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, TRPV1, TYR |
8.44601 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, AOX1, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FUT7, GBA2, PIM1, PPARA, TYR, XDH |
7.99275 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
7.90908 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, AKR1B10, ALPL, AOX1, BCL2, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MMP1, MMP2, MMP9, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, TNKS, TNKS2, TRPV1, TYR, XDH |
7.60208 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA, TRPV1 |
7.60208 |
[BP] GO:0033993 |
response to lipid
|
ALPL, BCL2, CA2, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, HSD11B2, HSD17B2, PRKCE, TYR |
7.50416 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
6.73131 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, AKR1B10, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PPARA, TRPV1 |
6.70824 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.69554 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, BCL2, CA2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, HSD11B2, PRKCE, PRKCG, TRPV1, TYR |
6.53717 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA, TRPV1 |
6.22508 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, AKR1B1, BCL2, CA12, CA2, CA7, CDK6, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, ESR1, F2, F3, FABP3, FABP4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MCL1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, TNKS, TNKS2, TRPV1, XDH |
6.1934 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, HSD11B2, PPARA, PRKCD, PRKCE, TRPV1 |
6.17824 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, CNR1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PRKCA, PRKCE |
5.60847 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, BCL2, CA3, CA9, CDK6, CNR1, CNR2, CYP1A1, CYP1B1, FABP3, HSD11B2, PRKCD, PRKCE, PRKCG, TRPV1 |
5.56979 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALPL, AOX1, BCL2, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FABP4, FUT7, GBA2, HSD17B1, HSD17B2, MMP1, MMP2, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, TNKS, TNKS2, TYR, XDH |
5.27225 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, HSD11B2, MMP2, PPARA, PRKCD, PRKCE, TRPV1 |
4.76566 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.72194 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.6421 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
CA2, CA7, CNR1, CNR2, PRKCE |
4.60424 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, AKR1B1, BCL2, CA2, CA7, CDC25B, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, MCL1, MMP1, MMP2, MMP9, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, TNKS, TNKS2, TRPV1, XDH |
4.36486 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.24124 |
[BP] GO:0018107 |
peptidyl-threonine phosphorylation
|
BCL2, CSNK2A1, PRKCA, PRKCB, PRKCD, TNKS |
4.15331 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, KCNA3, PPARA, PRKCB, PRKCE, TRPV1 |
3.96814 |
[BP] GO:0010647 |
positive regulation of cell communication
|
AKR1B1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F2, F3, MCL1, MMP9, PRKCA, PRKCB, PRKCD, PRKCE, PTPN1, TNKS, TNKS2, XDH |
3.95928 |
[BP] GO:0018210 |
peptidyl-threonine modification
|
BCL2, CSNK2A1, PRKCA, PRKCB, PRKCD, TNKS |
3.95928 |
[BP] GO:0023056 |
positive regulation of signaling
|
AKR1B1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F2, F3, MCL1, MMP9, PRKCA, PRKCB, PRKCD, PRKCE, PTPN1, TNKS, TNKS2, XDH |
3.94778 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, BCL2, CA3, CNR1, CNR2, CYP1A1, CYP1B1, PRKCD, PRKCE |
3.80539 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, ALPL, BCL2, CA2, CA9, CBR1, CDC25B, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, F2, FABP4, FUT7, GBA2, HSD11B1, HSD17B2, MCL1, MMP2, MMP9, PIM1, PPARA, PRKCA, PRKCD, TNKS2, TYR |
3.79294 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH |
3.79294 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, AKR1B1, BCL2, CA2, CA7, CDC25B, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, MCL1, MMP1, MMP2, MMP9, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, TNKS, TNKS2, TRPV1, XDH |
3.78659 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, AKR1B1, ALPL, BCL2, CA2, CA3, CA6, CA9, CDK6, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, F2, F3, FABP3, FABP4, HSD11B2, HSD17B2, MCL1, MMP2, MMP9, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, TRPV1, TYR |
3.73071 |
[BP] GO:0018105 |
peptidyl-serine phosphorylation
|
BCL2, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, TNKS |
3.57384 |
[BP] GO:0032501 |
multicellular organismal process
|
AKR1B1, AKR1B10, ALPL, BCL2, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, ESR1, ESRRB, F2, F3, FABP4, HSD11B2, HSD17B2, MCL1, MMP1, MMP2, MMP9, PIM1, PPARA, PRKCD, PRKCG, TNKS2, TRPV1, TYR |
3.53863 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.53152 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
AKR1B1, BCL2, CNR1, CSNK2A1, CYP1B1, ESRRA, F2, F3, FABP4, MCL1, MMP2, MMP9, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, TNKS, TNKS2, XDH |
3.51793 |
[BP] GO:0030168 |
platelet activation
|
F2, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG |
3.43407 |
[BP] GO:0080134 |
regulation of response to stress
|
CDK6, CNR1, CNR2, CYP19A1, ESR1, F2, F3, FABP4, MCL1, MMP2, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTPN1, XDH |
3.4273 |
[BP] GO:0018209 |
peptidyl-serine modification
|
BCL2, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, TNKS |
3.33402 |
[BP] GO:0032844 |
regulation of homeostatic process
|
BCL2, CA2, CA7, CDK6, CNR1, F2, PRKCE, TNKS, TNKS2, TRPV1 |
3.29847 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.1415 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, CNR1, CNR2, FABP3, HSD11B2, MMP2, PPARA, PRKCD, PRKCE, PRKCG, TRPV1, TYR |
3.09031 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.01434 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, BCL2, CA12, CA2, CA7, CNR1, ESR1, F2, FABP3, FABP4, PRKCB, PRKCE, TRPV1 |
2.89058 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, MCL1, MMP9, PIM1, PPARA, PRKCA, PRKCD, PRKCG, PTPN1, TRPV1, XDH |
2.82588 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, CNR1, CNR2, FABP3, HSD11B2, MMP2, PPARA, PRKCD, PRKCE, PRKCG, TRPV1, TYR |
2.78215 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.68344 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
CA2, CA7, PRKCE |
2.68344 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, AKR1B1, BCL2, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FABP4, MCL1, MMP9, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, TNKS, TNKS2, TRPV1, XDH |
2.68344 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, MCL1, MMP9, PIM1, PRKCA, PRKCD, PRKCG, PTPN1, TRPV1, XDH |
2.68165 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
AKR1B1, BCL2, CSNK2A1, CYP1B1, F2, F3, MCL1, MMP9, PRKCA, PRKCB, PRKCD, PRKCE, PTPN1, TNKS, TNKS2, XDH |
2.65535 |
[BP] GO:0044092 |
negative regulation of molecular function
|
CNR1, CNR2, CSNK2A1, CYP1B1, ESR1, FABP4, MMP9, PIM1, PPARA, PRKCA, PRKCD, PRKCE, PTPN1, TNKS |
2.65535 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, BCL2, CNR1, CSNK2A1, CYP1B1, ESR1, F3, MCL1, MMP9, PIM1, PRKCA, PRKCD, PRKCG, PTPN1, TRPV1, XDH |
2.65162 |
[BP] GO:0035408 |
None
|
PRKCA, PRKCB |
2.65162 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.65162 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, AKR1B10, ALPL, AOX1, BCL2, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MMP1, MMP2, MMP9, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, TNKS, TNKS2, TRPV1, TYR, XDH |
2.63756 |
[BP] GO:0048513 |
animal organ development
|
ACHE, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, HSD11B1, HSD17B2, PPARA, TYR |
2.62205 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, MMP9, PRKCD |
2.62205 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, ESR1, F2, F3, MMP2, MMP9, PIM1, PRKCA |
2.55429 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
BCL2, CYP1B1, F2, PRKCD, TRPV1, XDH |
2.55298 |
[BP] GO:0001666 |
response to hypoxia
|
BCL2, CYP1A1, HSD11B2, MMP2, PPARA, PRKCB, PRKCE |
2.52651 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA |
2.47563 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
BCL2, CYP1A1, HSD11B2, MMP2, PPARA, PRKCB, PRKCE |
2.44985 |
[BP] GO:0016042 |
lipid catabolic process
|
AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, GBA2 |
2.42541 |
[BP] GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress
|
BCL2, CYP1B1, PRKCD |
2.42541 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, BCL2, CA2, CA7, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1B1, F2, F3, KCNA3, MMP9, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, TRPV1 |
2.42541 |
[BP] GO:0050994 |
None
|
CNR1, PPARA, PRKCD, PRKCE |
2.40338 |
[BP] GO:0048583 |
regulation of response to stimulus
|
AKR1B1, BCL2, CDK6, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, F2, F3, FABP4, MCL1, MMP2, MMP9, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, TNKS, TNKS2, XDH |
2.39916 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.36548 |
[BP] GO:0042127 |
regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, ESR1, ESRRA, F2, F3, FABP3, MMP2, MMP9, PIM1, PRKCA, XDH |
2.36338 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
CNR1, CNR2, CYP19A1, ESR1, F2, F3, FABP4, PPARA, PRKCA, PRKCD, PRKCG |
2.36338 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CBR1, CYP1A1, CYP1A2, CYP1B1 |
2.36206 |
[BP] GO:0050727 |
regulation of inflammatory response
|
CNR1, CNR2, CYP19A1, ESR1, F2, FABP4, PPARA, PRKCD |
2.36206 |
[BP] GO:0031347 |
regulation of defense response
|
CNR1, CNR2, CYP19A1, ESR1, F2, FABP4, MMP2, PPARA, PRKCD, PRKCE, PTPN1 |
2.35468 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
CNR2, CYP19A1, F2, PPARA, PRKCD |
2.29885 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, BCL2, CA2, CA7, CNR1, CYP19A1, F2, KCNA3, MMP9, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, TRPV1 |
2.29885 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.29885 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.29885 |
[BP] GO:0070482 |
response to oxygen levels
|
BCL2, CYP1A1, HSD11B2, MMP2, PPARA, PRKCB, PRKCE |
2.2848 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, GBA2, PPARA |
2.28161 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, MMP2, MMP9, PRKCB, PRKCD, PRKCE, TRPV1 |
2.28161 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
BCL2, CDK6, CNR1, CNR2, CYP19A1, ESR1, ESR2, F2, MCL1, MMP9, PPARA, PRKCB, PRKCD, PTPN1, XDH |
2.28161 |
[BP] GO:0006950 |
response to stress
|
ACHE, AKR1B1, BCL2, CA2, CA3, CA9, CNR2, CYP1A1, CYP1A2, CYP1B1, F2, HSD11B2, MCL1, MMP2, MMP9, PPARA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, TRPV1 |
2.26204 |
[BP] GO:0050801 |
ion homeostasis
|
BCL2, CA12, CA2, CA7, ESR1, F2, FABP3, PRKCB, PRKCE, TRPV1 |
2.25543 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.22309 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP19A1, CYP1A1, CYP1B1, GBA2, TYR |
2.21815 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, AKR1B1, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, F2, F3, MCL1, MMP9, PRKCA, PRKCB, PRKCD, PRKCE, PTPN1, TNKS, TNKS2, XDH |
2.21815 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
F2, FABP3, PPARA, PRKCD, PRKCE |
2.20808 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, AKR1B10, ALPL, AOX1, BCL2, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MMP1, MMP2, MMP9, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, TNKS, TNKS2, TRPV1, TYR, XDH |
2.18719 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, AKR1B1, BCL2, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, F2, F3, MCL1, MMP9, PRKCA, PRKCB, PRKCD, PRKCE, PTPN1, TNKS, TNKS2, XDH |
2.18323 |
[BP] GO:0050996 |
None
|
PPARA, PRKCD, PRKCE |
2.18057 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
BCL2, CA2, CA7, F2, PRKCE, TRPV1 |
2.17824 |
[BP] GO:0002682 |
regulation of immune system process
|
BCL2, CA2, CDK6, CNR1, CNR2, CYP19A1, ESR1, ESRRA, F2, MMP2, PRKCA, PRKCB, PRKCD, PRKCE, PTPN1 |
2.17824 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
2.16725 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.13696 |
[BP] GO:0042592 |
homeostatic process
|
AKR1B1, BCL2, CA12, CA2, CA7, CNR1, ESR1, F2, FABP3, FABP4, MCL1, PRKCB, PRKCE, TRPV1 |
2.13079 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
2.12544 |
[BP] GO:1900076 |
regulation of cellular response to insulin stimulus
|
ESRRA, PRKCB, PRKCD, PTPN1 |
2.09241 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.09241 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.08749 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.08749 |
[BP] GO:0038171 |
None
|
CNR1, CNR2 |
2.08749 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.08749 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, ALPL, BCL2, CA2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, F2, GBA2, HSD11B1, HSD17B2, MCL1, MMP9, PIM1, PPARA, TYR |
2.0791 |
[BP] GO:0007165 |
signal transduction
|
AKR1B1, BCL2, CA1, CA2, CDK6, CNR1, CNR2, CSNK2A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F2, F3, MCL1, MMP2, MMP9, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, TNKS, TNKS2, TRPV1 |
2.04106 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, BCL2, CDK6, CYP1A1, CYP1B1, ESR1, FABP4, MMP2, PRKCB, PRKCD, PRKCE, TRPV1 |
2.03493 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
CA2, CA7, CNR1, F2, TNKS, TNKS2 |
2.02884 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, AKR1B1, AKR1B10, AOX1, BCL2, CA1, CA2, CA3, CA4, CA5A, CA5B, CA7, CBR1, CDC25B, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, F2, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MCL1, MMP2, MMP9, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, TNKS, TNKS2, TRPV1, TYR, XDH |
3.34677 |
[CC] GO:0048471 |
perinuclear region of cytoplasm
|
ACHE, AKR1B1, CA4, PRKCA, PRKCD, PRKCE, PRKCG, TNKS2, TYR |
1.78419 |
[CC] GO:0005829 |
cytosol
|
AKR1B1, AKR1B10, AOX1, BCL2, CA1, CA2, CA3, CA7, CBR1, CDC25B, CDK6, CSNK2A1, FABP3, FABP4, HSD17B1, MCL1, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, TNKS, TNKS2, TRPV1, TYR, XDH |
1.65728 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, AKR1B1, AKR1B10, ALPL, AOX1, BCL2, CA1, CA2, CA4, CA5A, CA5B, CA6, CBR1, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FUT7, GBA2, MCL1, MMP2, MMP9, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, TNKS, TNKS2, TYR, XDH |
1.51647 |
[CC] GO:0016020 |
membrane
|
ACHE, ALPL, BCL2, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, F2, F3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B2, KCNA3, MCL1, MMP2, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, TNKS, TNKS2, TRPV1, TYR |
1.25522 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
20.6266 |
[MF] GO:0046914 |
transition metal ion binding
|
AOX1, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PIM1, PPARA, PRKCA, PRKCB, PRKCG, PTPN1, TNKS, TYR, XDH |
18.9925 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
13.4225 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PPARA, PRKCA, PRKCB, PRKCG, PTPN1, TNKS |
12.6816 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.9763 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, AKR1B1, AKR1B10, ALPL, AOX1, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F2, F3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MMP1, MMP2, MMP9, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, TNKS, TNKS2, TYR, XDH |
9.70442 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALPL, AOX1, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F2, MMP1, MMP2, MMP9, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, TNKS, TNKS2, TRPV1, TYR, XDH |
9.16212 |
[MF] GO:0046872 |
metal ion binding
|
ALPL, AOX1, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F2, MMP1, MMP2, MMP9, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, TNKS, TNKS2, TRPV1, TYR, XDH |
8.68406 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALPL, AOX1, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, HSD17B1, MMP1, MMP2, MMP9, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, TNKS, TNKS2, TRPV1, TYR, XDH |
8.37868 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
7.95432 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, CBR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
6.55999 |
[MF] GO:0004697 |
None
|
PRKCA, PRKCB, PRKCD, PRKCE, PRKCG |
6.14596 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH |
4.7252 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, CBR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.37388 |
[MF] GO:0004698 |
None
|
PRKCA, PRKCB, PRKCG |
4.24124 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1 |
3.94778 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.79294 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.79294 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.57922 |
[MF] GO:0008289 |
lipid binding
|
ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, HSD11B2, HSD17B1, PPARA, TRPV1 |
3.53863 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.45318 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.42055 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.35864 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.25515 |
[MF] GO:0009931 |
None
|
PRKCA, PRKCB, PRKCG |
2.88888 |
[MF] GO:0010857 |
None
|
PRKCA, PRKCB, PRKCG |
2.78215 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.65162 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.65162 |
[MF] GO:0035403 |
None
|
PRKCA, PRKCB |
2.65162 |
[MF] GO:0005506 |
iron ion binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH |
2.65162 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.63756 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
2.61853 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.6169 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.39916 |
[MF] GO:0004949 |
None
|
CNR1, CNR2 |
2.29885 |
[MF] GO:0004699 |
None
|
PRKCD, PRKCE |
2.29885 |
[MF] GO:0008144 |
drug binding
|
ACHE, CDK6, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, TRPV1 |
2.16745 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.08749 |
[MF] GO:0004674 |
protein serine/threonine kinase activity
|
CDK6, CSNK2A1, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG |
2.01587 |